A leading business magazine read by the business leaders for staying ahead and managing challenges that comes right away in the ever changing world of business.
Return of the Sun
PUMMELLED • AS CLIMATE CHANGE COMES TO A HEAD, ITS EFFECTS ARE GETTING MORE PRONOUNCED. CYCLONE BIPARJOY, THE LATEST EXTREME WEATHER EVENT WITNESSED BY INDIA IN JUNE, WREAKED HAVOC ON THE WESTERN COAST
THE GREAT RECOVERY • FY23 was a bumper year for India Inc., which achieved record-breaking revenues and profits. Sectors such as banking, financial services and insurance (BFSI), power, auto and FMCG were the star performers, shows data. An analysis of NSE-listed firms by Business Today reveals that these companies have emerged stronger from the setback of Covid-19 and other curveballs such as geopolitical turmoil, rising interest rates and volatile commodity prices. Let’s take a closer look at the numbers:
GROWING BILATERAL TRADE
THE NEW TEAM A-I • The reception accorded to PM Modi by the US and the kind of deals inked attest to India’s status as a rising economic power
FRESH PACTS • INDIA AND THE US HAVE INKED OVER 30 AGREEMENTS IN FOUR BROAD AREAS UNDER THE US-INDIA COMPREHENSIVE GLOBAL AND STRATEGIC PARTNERSHIP. HERE ARE SOME SIGNIFICANT ONES:
Chip Dreams • While investments in the semiconductor space have been welcomed, persistence will be key
A NEW BEGINNING
Full Throttle • The mega aircraft deal inked by IndiGo will complement the development of a strong ecosystem of services in the world’s fastest-growing aviation market
The Battle for Gold • With Novel Jewels, the Aditya Birla Group is set to compete with Tata group’s Tanishq and Reliance Industries’ Reliance Jewels
Funnelling Progress • NaBFID has been mandated with evolving and deepening India’s infrastructure investments pipeline. Will it succeed?
Winning at Half-time • The BSE Midcap and Smallcap soared 14 per cent and 13 per cent, respectively, beating the benchmark Sensex in the first half of 2023
BOND PULL • With primary subscriptions for sovereign gold bonds closed, investors now have the option of buying them from the secondary market. But should they?
THE SHANGHVI AGAIN • POWERED BY ITS PROMOTER’S RENEWED FOCUS ON THE GLOBAL SPECIALTY DRUGS BUSINESS AND BEEFED UP BY A SPATE OF ACQUISITIONS, SUN PHARMACEUTICAL INDUSTRIES LTD HAS REGAINED ITS SHINE, EVEN AS DEEP CHALLENGES LOOM
BOOSTER SHOT • The top five growth drivers for Sun Pharma in the past five years
DEAL STREET • Sun Pharma’s top four acquisitions and in-licensing deals in recent times
INNOVATION PIPELINE • Sun Pharma’s specialty R&D pipeline has four molecules undergoing clinical trials
‘WE CONTINUE TO GROW FASTER THAN THE INDUSTRY’ • Sun Pharma Founder & MD Dilip Shanghvi on new targets and the way forward for India’s largest pharma company
ON A NEW JOURNEY
SCALING PEAK XV • BREAKING FREE FROM THE SEQUOIA MOTHERSHIP, PEAK XV PARTNERS EMBARKS ON A SOLO VOYAGE IN FAMILIAR BUT TREACHEROUS WATERS. EMPOWERED, YET FACING CHALLENGES, PEAK XV WIELDS SERIOUS CAPITAL HEFT AND NEW-FOUND INDEPENDENCE TO DOUBLE DOWN ON THE INDIA OPPORTUNITY
VIEW FROM THE PEAK
‘NOW, WE CAN FULLY EMBRACE FOUNDERS’ • Shailendra Singh, Managing Director of Peak XV Partners, talks about the opportunities after the split from Sequoia and much more
IN CONVERSATION WITH AMIT KALRA, HEAD, GBS CENTERS, INDIA
IN THE DRIVER’S SEAT • DHEERAJ HINDUJA HAS STEERED COMMERCIAL VEHICLES MAJOR ASHOK LEYLAND OUT OF THE RED LANE AND INTO THE BLACK, GROWING AT A FASTER PACE THAN THE INDUSTRY. THE GROWTH IS LIKELY TO SUSTAIN, EVEN AS THE COMPANY AIMS TO PLUG GAPS IN ITS PORTFOLIO AND PREPARE...